AMPHA B.V. Report issue

For profit Phase 1 Phase 3
Founded: Nijmegen Netherlands (2006)
Status: Defunct (2018)

Organization Overview

First Clinical Trial
2007
NCT00824447
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

AMPHA Nijmegen, Toernooiveld 220, 6525EC, Nijmegen, The Netherlands | AMPHA, Toernooiveld 220, 6525 EC Nijmegen, The Netherlands